load more
PDL BioPharma Inc acquires and manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. The operating segments of the company are Medical Devices, Strategic Positions, Pharmaceutical and Income Generating Assets, of which key revenue is derived from the Pharmaceutical segment. The Pharmaceutical segment consists of revenue derived from branded prescription medicine products sold under the name Tekturna and Tekturna HCT in the U.S, and Rasilez and Rasilez HCT in the rest of the world (collectively, the Noden Products). Geographically, the company operates in Europe, North America, Asia and Other countries, of which prime revenue is generated from Asia and North America.

Related Companies

TickerCompanyChg %Mkt Cap

undefined Frequently Asked Questions

Q

How do I buy undefined (PDLI) stock?

A

You can purchase shares of (: ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are undefined's (PDLI) competitors?

A

There are no as such competitors for .

Q

What is the target price for undefined (PDLI) stock?

A

There is no analysis for

Q

Current Stock Price for undefined (PDLI)?

A

The stock price for (: ) is $ last updated Invalid Date.

Q

Does undefined (PDLI) pay a dividend?

A

There are no upcoming dividends for . The last dividend paid out to investors was $0.06 on June 2, 2016.

Q

When is undefined (undefined:PDLI) reporting earnings?

A

does not have any upcoming earnings scheduled.

Q

Is undefined (PDLI) going to split?

A

There is no upcoming split for .

Q

What sector and industry does undefined (PDLI) operate in?

A

is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the .